openPR Logo
Press release

We listened your feedback for Transdermal and Microneedle Drug Delivery Conference

10-19-2022 02:22 PM CET | Health & Medicine

Press release from: SAE Media Group

We listened your feedback for Transdermal and Microneedle Drug

SAE Media Group's Transdermal and Microneedle Drug Delivery conference returns to London for the 2nd year on 23 - 24 January 2023 and will focus on exploring the advances in microneedle diagnostics through case studies and real-world examples, whilst engaging in modern strategies for topical and transdermal drug delivery.
Vaccine delivery will be a significant aspect of this year's agenda with a focus on microneedle delivery technologies as a mode for vaccine delivery, in the pursuit to increase vaccine stability and accessibility.
An outlook of the transdermal space will also be reviewed, including future directions and next steps required to advance the current field and accelerate access for patients and end users.
Find out more about the key topics discussed online at: www.transdermal-microneedle-delivery.co.uk/PR2openpr and register soon to SAVE £200 until 31 October 2022!

The two-day agenda offers you peer-to-peer networking with CEO's, Senior Vice presidents, Directors of Delivery Technologies, Heads of Product Development and many more.

Delegates attending will have the opportunity to:
Engage with senior industry opinion leaders presenting their experiences and case studies in innovative device design and advanced drug product formulation
Gain insights from notified body and competent authority representatives addressing key regulatory requirements
Understand how to optimize your lifecycle management strategy for a commercially successful device
Explore and benchmark against industry advances in device design through case studies and real-world examples

To view the full agenda and speaker line-up please visit the website at: www.transdermal-microneedle-delivery.co.uk/PR2openpr and grab your discounted ticket soon!

Contact Information:
For Sponsorship Packages Please Contact Daniele Moreschi on +44 (0)20 7827 6050 Or dmoreschi@smi-online.co.uk
For Delegate Enquiries, Contact Jamie Wilkinson on +44 (0) 20 7827 6136 Or jwilkinson@smi-online.co.uk
For media enquiries contact Richard Jones on +44 (0)20 7827 6088 or rjones@smi-online.co.uk

Transdermal and Microneedle Drug Delivery conference
24 - 24 January 2023
London, UK
www.transdermal-microneedle-delivery.co.uk/PR2openpr
@SAEMGPharma
#SAETransdermal

------------END -------------

Transdermal and Microneedle Drug Delivery conference
24 - 24 January 2023
London, UK
www.transdermal-microneedle-delivery.co.uk/PR2openpr
@SAEMGPharma
#SAETransdermal

About SAE Media Group Conferences:
SAE Media Group Conferences connects global communities with focused networking conferences. We provide our customers with solutions through industry knowledge and collaboration that enables our attendees to return to their organisations better equipped to overcome their key business challenges. Our key events focus on Defence and Aerospace, Pharmaceutical and Medical. Each year we bring together over 5,000 senior business professionals at our conferences. http://www.smgconferences.com
SAE Media Group (SMG), a subsidiary of SAE International, reports the latest technology breakthroughs and design innovations to a global audience of nearly 1,000,000 engineers, researchers, and business managers. SMG provides critical information these professionals need to develop new and improved products and services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release We listened your feedback for Transdermal and Microneedle Drug Delivery Conference here

News-ID: 2772524 • Views:

More Releases from SAE Media Group

Conference Co-chairs from Merck & AstraZeneca invitation to join 3D Cell Culture
Conference Co-chairs from Merck & AstraZeneca invitation to join 3D Cell Culture
SAE Media Group reports: Conference co-chairs invite delegates to join the anticipated 6th Annual 3D Cell Culture Conference SAE Media Group is delighted to announce the return of successful 3D Cell Culture Conference for its 6th year, taking place on 8 and 9 February 2023 in London, UK. The 2023 Conference theme is on exploring the implementation of complex in-vitro models for drug development Visit the website at http://www.3d-cellculture.com/PR2 to find out
Exploring the Implementation of Complex In-vitro Models for Drug Development
Exploring the Implementation of Complex In-vitro Models for Drug Development
SAE Media Group reports: Agenda and speaker overview released for the 6th Annual 3D Cell Culture Conference, London, UK SAE Media Group is delighted to announce the return of successful 3D Cell Culture Conference for its 6th year, taking place on 8 and 9 February 2023 in London, UK. 3D Cell Culture has gained increasing momentum in the pharmaceutical industry over recent years, with the global 3D Cell Culture market predicted to
Co-Chairs from Aerie Pharmaceuticals & Santen Inc USA Invite Industry Experts to join Ophthalmic Drugs
Co-Chairs from Aerie Pharmaceuticals & Santen Inc USA Invite Industry Experts to …
The 5th Annual Ophthalmic Drugs Conference will take place in London at the Copthorne Tara Hotel on 21 and 22 November 2022. This event is less than four weeks away. The conference will explore advancements in ophthalmic treatments and variety of novel drugs, which are showing great clinical trial data. There will also be a specific focus on drug delivery along with advancements in novel technologies. Further key areas will be
Senior Officers and Military leaders and Experts from around the globe will speak at SAE Media Group's Maritime Reconnaissance and Surveillance Technology 2023
Senior Officers and Military leaders and Experts from around the globe will spea …
SAE Media Group are delighted to announce the return of the 8th Annual Maritime Reconnaissance and Surveillance Technology Conference, taking place in London on the 1st and 2nd of February 2023 at the Copthorne Tara Hotel. All the information you need for the event is now available! We remain as the only Maritime ISR conference focusing solely on Space-Based Domain Awareness. In this year's upcoming event, you will be able

All 5 Releases


More Releases for Transdermal

Global Transdermal Skin Patches Market | Global Transdermal Skin Patches Industr …
The transdermal skin patches market comprises of sales of transdermal skin patches products and connected services utilize to deliver medicine to the human body through patches. The Transdermal skin patches comprise the usage of adhesive patches made up of polymers that comprises drugs. The drug from such patches are absorbed into the body and ultimately into the blood stream disregarding the drug delivery through pill, or injections. According to the
Transdermal Patch Market Report 2018: Segmentation by Product (Fentanyl Transder …
Global Transdermal Patch market research report provides company profile for Actavis, Mundipharma, Henan Lingrui Pharmaceutical, Changzhou Siyao, Rfl Pharmaceutical, Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018
Transdermal Scopolamine Market Evolution / Developments
A new study by Transparency Market Research (TMR) indicates that Novartis AG, alone, contributed nearly 41.0% of the overall revenue of the global transdermal scopolamine market in 2016. Other two torch bearers in the market, namely, GlaxoSmithKline Plc and Baxter International Inc., commanded a cumulative share of 49.0% in the same year. Even though, the number of small players in the market is less, the degree of competition within the
Transdermal Drug Delivery System Market 2017 -
Apex Research, recently published a detailed market research study focused on the "Transdermal Drug Delivery System Market" across the global, regional and country level. The report provides 360° analysis of "Transdermal Drug Delivery System Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Transdermal Drug Delivery System industry, and estimates the future
US Transdermal Patch Market US Transdermal Sales Report 2020
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Transdermal Patch 2. Classification of Transdermal Patches 2.1 Single/ Multiple-Layer Drug-in-Adhesive 2.2 Reservoir Transdermal Patches 2.3 Matrix Based Transdermal Patches 2.4 Vapor Patch 2.5 Active and Passive Patch 3. Why There Exist Need for Transdermal Patches? 4. Mechanism of Transdermal Patch Drug Delivery 4.1 Properties of Transdermal Therapeutics 4.2 Components of
Transdermal Patch Market Transdermal Patch Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Transdermal Patch Classification of Transdermal Patches 2.1 Single/ Multiple-Layer Drug-in-Adhesive 2.2 Reservoir Transdermal Patches 2.3 Matrix Based Transdermal Patches 2.4 Vapor Patch 2.5 Active and Passive Patch Why There Exist Need for Transdermal Patches? Mechanism of Transdermal Patch Drug Delivery 4.1 Properties of Transdermal Therapeutics 4.2 Components of Transdermal Patch 4.3